These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34303789)

  • 1. Sphingolipid imbalance and inflammatory effects induced by uremic toxins in heart and kidney cells are reversed by dihydroceramide desaturase 1 inhibition.
    Savira F; Magaye R; Scullino CV; Flynn BL; Pitson SM; Anderson D; Creek DJ; Hua Y; Xiong X; Huang L; Liew D; Reid C; Kaye D; Kompa AR; Wang BH
    Toxicol Lett; 2021 Oct; 350():133-142. PubMed ID: 34303789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of dihydroceramide desaturase 1 inhibition on endothelial impairment induced by indoxyl sulfate.
    Savira F; Kompa AR; Kelly DJ; Magaye R; Xiong X; Huang L; Liew D; Reid C; Kaye D; Scullino CV; Pitson SM; Flynn BL; Wang BH
    Vascul Pharmacol; 2021 Dec; 141():106923. PubMed ID: 34600152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablation of dihydroceramide desaturase confers resistance to etoposide-induced apoptosis in vitro.
    Siddique MM; Bikman BT; Wang L; Ying L; Reinhardt E; Shui G; Wenk MR; Summers SA
    PLoS One; 2012; 7(9):e44042. PubMed ID: 22984457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-Bound Uremic Toxins in Hemodialysis Patients Relate to Residual Kidney Function, Are Not Influenced by Convective Transport, and Do Not Relate to Outcome.
    van Gelder MK; Middel IR; Vernooij RWM; Bots ML; Verhaar MC; Masereeuw R; Grooteman MP; Nubé MJ; van den Dorpel MA; Blankestijn PJ; Rookmaaker MB; Gerritsen KGF
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32272776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasculopathy in the setting of cardiorenal syndrome: roles of protein-bound uremic toxins.
    Guo J; Lu L; Hua Y; Huang K; Wang I; Huang L; Fu Q; Chen A; Chan P; Fan H; Liu ZM; Wang BH
    Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H1-H13. PubMed ID: 28411233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring binding characteristics and the related competition of different protein-bound uremic toxins.
    Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S
    Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Hayashi Y; Tsuchiya K; Yamamoto M; Nemoto-Sasaki Y; Tanigawa K; Hama K; Ueda Y; Tanikawa T; Gohda J; Maeda K; Inoue JI; Yamashita A
    J Virol; 2021 Aug; 95(17):e0080721. PubMed ID: 34106748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved dialytic removal of protein-bound uremic toxins by intravenous lipid emulsion in chronic kidney disease rats.
    Shi Y; Zhang Y; Tian H; Wang Y; Shen Y; Zhu Q; Ding F
    Nephrol Dial Transplant; 2019 Nov; 34(11):1842-1852. PubMed ID: 31071223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Protein-Bound Uremic Toxins and Asymptomatic Cardiac Dysfunction in Patients with Chronic Kidney Disease.
    Chinnappa S; Tu YK; Yeh YC; Glorieux G; Vanholder R; Mooney A
    Toxins (Basel); 2018 Dec; 10(12):. PubMed ID: 30563136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myristic acid increases the activity of dihydroceramide Delta4-desaturase 1 through its N-terminal myristoylation.
    Beauchamp E; Goenaga D; Le Bloc'h J; Catheline D; Legrand P; Rioux V
    Biochimie; 2007 Dec; 89(12):1553-61. PubMed ID: 17716801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P
    Kamprom W; Tawonsawatruk T; Mas-Oodi S; Anansilp K; Rattanasompattikul M; Supokawej A
    Int J Med Sci; 2021; 18(3):744-755. PubMed ID: 33437209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-Bound Uremic Toxins and Immunity.
    Rocchetti MT; Cosola C; Ranieri E; Gesualdo L
    Methods Mol Biol; 2021; 2325():215-227. PubMed ID: 34053061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs Commonly Applied to Kidney Patients May Compromise Renal Tubular Uremic Toxins Excretion.
    Mihaila SM; Faria J; Stefens MFJ; Stamatialis D; Verhaar MC; Gerritsen KGF; Masereeuw R
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32545617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uremic Toxin Concentrations are Related to Residual Kidney Function in the Pediatric Hemodialysis Population.
    Snauwaert E; Holvoet E; Van Biesen W; Raes A; Glorieux G; Vande Walle J; Roels S; Vanholder R; Askiti V; Azukaitis K; Bayazit A; Canpolat N; Fischbach M; Godefroid N; Krid S; Litwin M; Obrycki L; Paglialonga F; Ranchin B; Samaille C; Schaefer F; Schmitt CP; Spasojevic B; Stefanidis CJ; Van Dyck M; Van Hoeck K; Collard L; Eloot S; Shroff R
    Toxins (Basel); 2019 Apr; 11(4):. PubMed ID: 31022857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adsorption of Protein-Bound Uremic Toxins Using Activated Carbon through Direct Hemoperfusion in vitro.
    Yamamoto S; Ito T; Sato M; Goto S; Kazama JJ; Gejyo F; Narita I
    Blood Purif; 2019; 48(3):215-222. PubMed ID: 31055586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets.
    Lim YJ; Sidor NA; Tonial NC; Che A; Urquhart BL
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33668632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adsorption of Protein-Bound Uremic Toxins Through Direct Hemoperfusion With Hexadecyl-Immobilized Cellulose Beads in Patients Undergoing Hemodialysis.
    Yamamoto S; Sato M; Sato Y; Wakamatsu T; Takahashi Y; Iguchi A; Omori K; Suzuki Y; Ei I; Kaneko Y; Goto S; Kazama JJ; Gejyo F; Narita I
    Artif Organs; 2018 Jan; 42(1):88-93. PubMed ID: 28703401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH-Dependent Protein Binding Properties of Uremic Toxins In Vitro.
    Yamamoto S; Sasahara K; Domon M; Yamaguchi K; Ito T; Goto S; Goto Y; Narita I
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33557434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydroceramide desaturase 1 (DES1) promotes anchorage-independent survival downstream of HER2-driven glucose uptake and metabolism.
    Linzer RW; Guida DL; Aminov J; Snider JM; Khalife G; Buyukbayraktar AB; Alhaddad C; Resnick AE; Wang P; Pan CH; Allopenna JJ; Clarke CJ
    FASEB J; 2022 Oct; 36(10):e22558. PubMed ID: 36165222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydroceramide desaturase and dihydrosphingolipids: debutant players in the sphingolipid arena.
    Fabrias G; Muñoz-Olaya J; Cingolani F; Signorelli P; Casas J; Gagliostro V; Ghidoni R
    Prog Lipid Res; 2012 Apr; 51(2):82-94. PubMed ID: 22200621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.